Evidence map›Paper›PMID 33971954›Full record

ArticleBiotechnology for biofuels2021

Synergistic mechanism of GH11 xylanases with different action modes from Aspergillus niger An76.

Shu Zhang, Sha Zhao, Weihao Shang, Zijuan Yan, Xiuyun Wu, Yingjie Li, Guanjun Chen, Xinli Liu, Lushan Wang

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Whole-genome analysis and enzymatic profiling of Bacillus spizizenii as a xylanase-producing source from Iran.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  2. Article
  3. Article
  4. Harnessing Xylanase Potential inJournal of fungi (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Expression inInternational journal of molecular sciences · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shu ZhangState Key Laboratory of Microbial Technology, Institute of Microbial Technology, Shandong University, Qingdao, 266237, Shandong, China.
Sha ZhaoState Key Laboratory of Microbial Technology, Institute of Microbial Technology, Shandong University, Qingdao, 266237, Shandong, China.
Weihao ShangState Key Laboratory of Microbial Technology, Institute of Microbial Technology, Shandong University, Qingdao, 266237, Shandong, China.
Zijuan YanSchool of Life Sciences, Shandong University, Qingdao, 266237, Shandong, China.
Xiuyun WuState Key Laboratory of Microbial Technology, Institute of Microbial Technology, Shandong University, Qingdao, 266237, Shandong, China. wuxiuyun3353@163.com.
Yingjie LiState Key Laboratory of Microbial Technology, Institute of Microbial Technology, Shandong University, Qingdao, 266237, Shandong, China.
Guanjun ChenState Key Laboratory of Microbial Technology, Institute of Microbial Technology, Shandong University, Qingdao, 266237, Shandong, China.
Xinli LiuState Key Laboratory of Biobased Material and Green Papermaking, Qilu University of Technology, Shandong Academy of Sciences, Jinan, 250353, Shandong, China.
Lushan WangState Key Laboratory of Microbial Technology, Institute of Microbial Technology, Shandong University, Qingdao, 266237, Shandong, China.
Shandong University · CNShandong Academy of Sciences · CN

Funding

Foundation of State Key Laboratory of Biobased Material and Green Papermaking No. GZKF202020Key Technology Research and Development Program of Shandong No. 2020CXGC010601
6 · The paper itself

Abstract

backgroundXylan is the most abundant hemicellulose polysaccharide in nature, which can be converted into high value-added products. However, its recalcitrance to breakdown requires the synergistic action of multiple enzymes. Aspergillus niger, possessing numerous xylan degrading isozyme-encoding genes, are highly effective xylan degraders in xylan-rich habitats. Therefore, it is necessary to explore gene transcription, the mode of action and cooperation mechanism of different xylanase isozymes to further understand the efficient xylan-degradation by A. niger.

resultsAspergillus niger An76 encoded a comprehensive set of xylan-degrading enzymes, including five endo-xylanases (one GH10 and four GH11). Quantitative transcriptional analysis showed that three xylanase genes (xynA, xynB and xynC) were up-regulated by xylan substrates, and the order and amount of enzyme secretion differed. Specifically, GH11 xylanases XynA and XynB were initially secreted successively, followed by GH10 xylanase XynC. Biochemical analyses displayed that three GH11 xylanases (XynA, XynB and XynD) showed differences in catalytic performance and product profiles, possibly because of intricate hydrogen bonding between substrates and functional residues in the active site architectures impacted their binding capacity. Among these, XynB had the best performance in the degradation of xylan and XynE had no catalytic activity. Furthermore, XynA and XynB showed synergistic effects during xylan degradation.

conclusionsThe sequential secretion and different action modes of GH11 xylanases were essential for the efficient xylan degradation by A. niger An76. The elucidation of the degradation mechanisms of these xylanase isozymes further improved our understanding of GH-encoding genes amplification in filamentous fungi and may guide the design of the optimal enzyme cocktails in industrial applications.

Indexed as

Aspergillus nigerDegradation patternGH11 xylanasesSynergistic hydrolysisTranscription analysis

Identifiers

PMID33971954
PMCPMC8112042
OpenAlexW3160163086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.